Showing results (291-300 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|September 26, 2003
Global genechip profiling to identify genes responsive to p53-induced growth arrest and apoptosis in human lung carcinoma cellsMegan Robinson, Ping Jiang, Jenny Cui, et al.Cancer Biology & Therapy|September 26, 2003
Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cellsJose R Conejo-Garcia, Fabian Benencia, Maria C Courreges, et al.Cancer Biology & Therapy|November 14, 2003
Targeting adult and pediatric cancers via cell-based vaccines and the prospect of activated B lymphocytes as a novel modalityChristina M Coughlin, Robert H VonderheideCancer Biology & Therapy|November 14, 2003
Apoptosis genes and resistance to cancer therapy: what does the experimental and clinical data tell us?J Martin Brown, George WilsonCancer Biology & Therapy|November 14, 2003
Clinicopathologic and molecular features of Hodgkin's lymphomaAnas Younes, Antonio CarboneCancer Biology & Therapy|November 14, 2003
Enhanced adenovirus infection of melanoma cells by fiber-modification: incorporation of RGD peptide or Ad5/3 chimerismAndrea L Volk, Angel A Rivera, Anna Kanerva, et al.Cancer Biology & Therapy|November 14, 2003
Altered HOX gene expression in human skin and breast cancer cellsTerje Svingen, Kathryn F TonissenCancer Biology & Therapy|November 14, 2003
Induction of apoptosis in BCR/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF/MEK/ERK and JNK pathwaysChunrong Yu, Mark Subler, Mohamed Rahmani, et al.Cancer Biology & Therapy|November 14, 2003
Apoptotic response to 5-fluorouracil treatment is mediated by reduced polyamines, non-autocrine Fas ligand and induced tumor necrosis factor receptor 2Wei Zhang, Latha Ramdas, Weiping Shen, et al.Cancer Biology & Therapy|November 14, 2003
Tumor expression of 4-1BB ligand sustains tumor lytic T cellsHua Zhang, Melinda S Merchant, Kevin S Chua, et al.Pageof 387